FMP
Salarius Pharmaceuticals, Inc.
SLRX
NASDAQ
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. The company is headquartered in Houston, Texas.
2.69 USD
0.07 (2.6%)
We are unable to load the chart at this time.
Date
Revenue
Earnings
Estimated Earnings
Surprise
2024-11-14
0
-0.76
-2.4
-68.33%
2024-08-09
0
-2.37
-53.6
-95.58%
2024-05-13
0
-3.28
-53.6
-93.88%
2024-03-22
0
-1.76
-8.08
-78.22%
2023-11-09
0
-0.65
-1.07
-39.25%
2023-08-10
0
-1.43
-1.26
13.49%
2023-05-11
0
-2.23
-1.98
12.63%
2023-03-27
0
-2.83
-2.07
36.71%
2022-11-10
0
-2.47
-2.85
-13.33%
2022-08-08
0
-2.25
-2.75
-18.18%
2022-05-12
0
-3.25
-2.25
44.44%
2022-03-10
-1.84M
-2.25
-2.5
-10.00%
2021-11-04
0
-2
-2.25
-11.11%
2021-08-05
571.39k
-1.75
-1.5
16.67%
2021-05-12
1.27M
-1.5
-1.25
20.00%
2021-03-18
1.48M
-2.5
0
-
2020-11-11
1.38M
-2.5
-2.5
0.00%
2020-08-12
1.24M
-3.25
-4
-18.75%
2020-05-14
1.13M
-5.5
-11
-50.00%
2020-03-23
1.04M
-0.44
0
-
2019-11-13
874.95k
-26
0
-
2019-07-17
164.71k
-50
0
-
2019-03-31
104.98k
-77.16
0
-
2019-03-06
163k
-69.5
0
-
2018-11-05
250.99k
-91.27
0
-
2018-08-01
245.5k
-312.5
-281.25
11.11%
2018-05-02
178.58k
-287.5
-303.12
-5.15%
2018-03-07
283k
-287.5
-356.25
-19.30%
2017-11-06
413.6k
-337.5
-378.12
-10.74%
2017-08-02
335.52k
-318.75
-359.37
-11.30%
2017-05-03
242.55k
-262.5
-387.5
-32.26%
2017-03-08
299k
-250
-462.5
-45.95%
2016-11-02
599.07k
-406.25
-452.08
-10.14%
2016-08-03
112.69k
-443.75
-419.79
5.71%
2016-05-04
0
-381.25
-352.5
8.16%
2016-03-08
0
-318.75
-352.5
-9.57%
2015-11-04
0
-331.25
-276.25
19.91%
2015-08-05
0
-293.75
-228.12
28.77%
2015-05-06
0
-368.75
-181.25
103.45%
2015-02-04
0
-137.41
-3.5
3826.05%
2014-09-30
0
-219.74
0
-
2014-06-30
0
-242.22
0
-